Science Explorer Back to mapMap
Discussion
Researcher · University of Lisbon · Portugal

Marc Veldhoen

Marc Veldhoen publishes mostly in Immunology, Infectious Diseases and Molecular Biology, on topics such as T-cell and B-cell Immunology, Immune Cell Function and Interaction and SARS-CoV-2 and COVID-19 Research.

ORCID 0000-0002-1478-9562 OpenAlex
World rank
#83,275
of 7,710,434 ranked researchers
Rank in Portugal
#129
of 41,760
Works
153
Citations
20k
Citations per work
127.5
h-index
49
i10-index 78Top 4.5% in Immunology
Marc Veldhoen

What does Marc Veldhoen research?

Marc Veldhoen's work is mostly in Immunology and Microbiology (49%), Medicine (19%), Biochemistry, Genetics and Molecular Biology (9%).

Life Sciences: 89 works · 58.2% of their workImmunology and Microbiology: 75 works · 49.3% of their workImmunology: 75 works · 49.3% of their workBiochemistry, Genetics and Molecular Biology: 14 works · 8.9% of their workMolecular Biology: 9 works · 6.2% of their workGenetics: 4 works · 2.7% of their workEverything else: 32 works · 20.6% of their workHealth Sciences: 29 works · 18.8% of their workMedicine: 29 works · 18.8% of their workInfectious Diseases: 23 works · 15.0% of their workOncology: 6 works · 3.8% of their workPhysical Sciences: 4 works · 2.4% of their workMathematics: 4 works · 2.4% of their workModeling and Simulation: 4 works · 2.4% of their workTHEIR WORKMarc Veldhoen153works
Life Sciences58%Physical Sciences2%Health Sciences19%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology7549.3%
    2. Biochemistry, Genetics and Molecular Biology148.9%
  2. Everything else3220.6%
    1. Medicine2918.8%
    1. Mathematics42.4%
  1. 1Immunology49% of their works
  2. 2Infectious Diseases15% of their works
  3. 3Molecular Biology6% of their works
  4. 4Oncology4% of their works
  5. 5Genetics3% of their works
  6. 6Modeling and Simulation2% of their works

Research topics

Which keywords describe Marc Veldhoen's research?

The keywords of their largest research topics: TGF-ß, CD4+CD25+, Foxp3, Immunity, Natural Killer Cells, NK Cell Recognition, ACE2 Receptor and SARS-CoV-2.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. TGF-ß662 topics
  2. CD4+CD25+491 topic
  3. Foxp3491 topic
  4. Immunity482 topics
  5. NK Cell Recognition461 topic
  6. Natural Killer Cells461 topic
  7. ACE2 Receptor442 topics
  8. SARS-CoV-2442 topics
  9. Regulatory T Cells322 topics
  10. Coronavirus271 topic
  11. Vaccine271 topic
  12. Cancer Immunotherapy211 topic
  13. Dendritic Cells211 topic
  14. Clinical Characteristics171 topic
  15. Epidemiology171 topic
  16. IL-17171 topic
  17. TH17 Cells171 topic
  18. IL-33151 topic
  19. Innate Lymphoid Cells151 topic
  20. Genetic Mutations121 topic
  21. Primary Immunodeficiency121 topic

Where does Marc Veldhoen work?

Marc Veldhoen's main affiliation in the publication record is University of Lisbon, Portugal.

How many publications and citations does Marc Veldhoen have?

OpenAlex counts 153 works and 19,513 citations for Marc Veldhoen, an h-index of 49, ranking #83,275 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Marc Veldhoen. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.